US3433783A - Method for the production of ribonucleoside-5'-phosphate - Google Patents

Method for the production of ribonucleoside-5'-phosphate Download PDF

Info

Publication number
US3433783A
US3433783A US650661A US3433783DA US3433783A US 3433783 A US3433783 A US 3433783A US 650661 A US650661 A US 650661A US 3433783D A US3433783D A US 3433783DA US 3433783 A US3433783 A US 3433783A
Authority
US
United States
Prior art keywords
ribonucleoside
water
phosphate
mixture
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US650661A
Inventor
Mikio Honja
Kin-Ichi Imai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of US3433783A publication Critical patent/US3433783A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation

Definitions

  • This invention is concerned with a method for the production of ribonucleoside--phosphate, which comprises reacting the ribonucleoside with metaboric acid and thereupon forthwith reacting the product with phosphorylating agent, and subsequently converting the resulting product into ribonucleoside-5-phosphate by the action of water.
  • nucleoside-5'-phosphates have been used as condiments in the production of various foods, by virtue of their characteristic flavor enhancing or seasoning qualities.
  • Ribonucleosides have three hydroxyl groups, i.e. one at each of the 2'-, 3'- and 5'-positions on their ribose moiety, and therefore in order to produce ribonucleoside- 5'-phosphate selectively from the corresponding ribonucleoside, it is necessary to protect the hydroxyl groups at the 2- and 3'-positions with suitable substituents prior to the phosphorylation at the 5'-position.
  • the hitherto known methods for the production of ribonucleoside-5'-phosphates starting with the corresponding ribonucleosides consists of protecting the 2.- and 3- hydroxyl groups on the ribose moiety with acyl groups or isopropylidene groups, followed by phosphorylation of the free 5-hydroxyl group by an appropriate agent and then by removal of the protecting group or groups.
  • the hitherto known methods are bound up with troublesome and disadvantageous steps. That is to say, in addition to a step for the protection of the 2- and 3-hydroxyl groups prior to subsequent phosphorylation at the 5'-position, the methods necessarily include a troublesome step for removing the protecting groups from the phosphorylated product.
  • the protecting groups are acyl groups
  • a treatment with methanolic ammonia must be carried out
  • the protecting group is an isopropylidene group
  • the isopropylidene group must be removed by heating the phosphorylated product under acidic conditions in a step subsequent to the phosphorylation reaction, and these manipulations are diificult and disadvantageous from the technical point of view.
  • the invention in its broader aspects contemplates providing a new selective phosphorylation of the 5'-hydroxyl group on the ribose moiety of ribonucleoside.
  • Another object of the invention is to make it very simple to remove the protecting groups at the 2'- and 3-positions after the phosphorylation reaction. That is to say, in accordance with the invention, the product resulting from the phosphorylation procedure or the reaction mixture is merely contacted with water to achieve removal of the protecting groups, and therefore the present method for the production of ribonucleoside-5-phos phates is a preferable one from an industrial point of view, as it does not include such troublesome procedures as the deacylation involved in the method heretofore employed in the art, which is far from satisfactory from an industrial point of view.
  • the result, according to the in vention is that ribonucleoside-5'-phosphate can be produced in good yield by simple procedures.
  • Ribonucleosides in the present specification comprise those containing a purine or pyrimidine base, and include the naturally occurring as Well as the synthetic ribonucleosides.
  • the present invention comprises reacting the starting ribonucleoside with metaboric acid and thereupon forthwith reacting the product with phosphorylating agent, and subsequently converting the resulting product into ribonucleoside-5-phosphate by the action of water.
  • the characteristic feature, in carrying the invention into practice, is that metaboric acid is, first of all, reacted with the starting ribonucleoside to selectively protect the hydroxyl groups at the 2'- and 3'-positions on the ribose moiety of the ribonucleoside.
  • the rnetaboric acid used in the present invention can either be in free form or in the form of salt such as ammonium salt, sodium salt, etc.
  • the reaction proceeds by heating a mixture of metaboric acid and ribonucleoside in an organic solvent. Any solvent may be used unless the reaction is thereby hindered.
  • the other conditions such as reaction temperature and reaction time, are adapted to the particular starting material.
  • metaboric acid forms a complex with the hydroxyl groups at the 2- and 3-positions on the ribose moiety.
  • the next step in the method of the present invention is phosphorylation of the 5hydroxyl group on the ribose moiety.
  • the product need not be separated from the reaction mixture, i.e. the latter can be directly phosphorylated, as such.
  • any of the known methods are applicable.
  • the agents which are preferably used for the present phosphorylation there are included phosphoryl chlorides such as diphenylphosphoryl chloride and dibenzylphosphoryl chloride, phosphoric acid anhy- 3 drides such as O-benzylphosphorus 0,0 diphenylphosphoric acid anhydride and tetra-p-nitrophenyl-pyrophosphoric acid anhydride, pyrophosphoryl mono-, dior tetrachloride, and the mixture of phosphorus oxychloride and water, etc.
  • phosphoryl chlorides such as diphenylphosphoryl chloride and dibenzylphosphoryl chloride
  • phosphoric acid anhy- 3 drides such as O-benzylphosphorus 0,0 diphenylphosphoric acid anhydride and tetra-p-nitrophenyl-pyrophosphoric acid anhydride
  • pyrophosphoryl mono-, dior tetrachloride pyrophosphoryl mono-, di
  • the product resulting from the phosphorylation is subsequently brought into contact with water or an organic solvent containing water.
  • the phosphorylated product need not be separated from the reaction mixture, but the latter can directly be brought into contact with water, or an organic solvent containing water.
  • the present method is extremely advantageous from the industrial point of view.
  • the present method is characterized by extreme simplicity of procedure for removal of any protecting groups.
  • the resulting final product i.e. ribonucleoside-'-phosphate can be isolated from the reaction mixture by methods per se well known in the art, for example using ion-exchange resins or active carbon, or by crystallizing in a form of salt such as sodium salt, barium salt, potassium salt, amino acid salt, etc.
  • ribonucleoside5-phosphate can be obtained in very simple procedure and under very moderate conditions as compared with those of known methods, and yet the reaction is completed in a short period of time. Moreover, the 5'-phosphate is obtained in high purity and good yield.
  • Example 1 To 300 milliliters of meta-cresol were added 5 grams of adenosine, 1.12 grams of metaboric acid and 72 milliliters of acetone. The mixture was warmed at 40 C. under stirring for one hour to give a solution. After the solution was cooled to 5 C., 40.5 grams of pyrophosphoryl tetrachloride were dropwise added thereto and the mixture was left for 3 hours. The reaction mixture was poured ether. The ether layer was washed with water. The washing and the above-obtained ice water layer were combined, and the combined solution was adjusted to pH 1 with normal solution of sodium hydroxide. Paper electrophoresis showed that adenosine-S-monophosphate was produced in yield of 92%.
  • Example 2 To a suspension of 133 milligrams of well dried adenosine in milliliters of acetone, were added 22 milligrams of metaboric acid. The mixture was heated at 70 C. for 3 hours and the solvent evaporated under reduced pressure. One milliliter of pyrophosphoryl tetrachloride was added to the residue under ice cooling and the mixture was left standing at 10 C. for 3 hours to give a homogeneous solution, which was poured into ice water. The mixture was adjusted to pH 1 with normal solution of sodium hydroxide and then adsorbed on a charcoal column. The column was washed with water and eluted with 50% aqueous ethanol containing 0.5% by volume of ammonium hydroxide.
  • the eluate was concentrated and examined by paper electrophoresis (0.05 mol borate, pH 9.2). This showed that adenosine-5-monophosphate was produced in yield of 70%.
  • the concentrate was poured onto a column of Amberlite C6400 (C1 form), which was into ice Water, and meta-cresol was extracted with eluted with 0.003 normal hydrochloric acid. After the obtained eluate was adsorbed on a charcoal column, the column was washed with water and eluted with aforesaid ethanol solution.
  • the eluate was concentrated after the addition of sodium hydroxide and then ethanol was added thereto to give colorless crystals of disodium salt of adenosine-5'-monophosphate.
  • Example 3 To a solution of 107 milligrams of inosine in 8 milliliters of dimethylformamide, were added 17.6 milligrams of metaboric acid. The mixture was heated at 70 C. for 3 hours and the solvent evaporated under reduced pressure. 0.8 milliliter of pyrophosphoryl tetrachloride was added to the residue under ice cooling and the mixture was left standing at 10 C. for 3 hours to give a homogeneous solution. The solution was treated in the same way as in Example 2.
  • Example 4 To 107 milligrams of inosine dissolved in 16 milliliters of acetone, were added 17.6 milligrams of metaboric acid. After the mixture was refiuxed for 30 minutes, it was subsequently treated in the same way as in Example 3 to give disodium salt of inosine-5'-monophosphate.
  • Example 5 A mixture of 113 milligrams of guanosine, l8 milligrams of metaboric acid and 8 milliliters of actone was refluxed for 3 hours and the acetone evaporated under reduced pressure. 08 milliliter of pyrophosphoryl tetrachloride -was added to the residue under ice cooling and the mixture was left standing at 10 C. for 3 hours to give a homogeneous solution. The solution was poured into 20 milliliters of normal sodium hydroxide solution to adjust to pH 2, and was adsorbed on a charcoal column. The column was washed with water and eluted.
  • the eluate was applied on top of a column of Amberlite CG 400 (C1 form), which was eluted with 0.003 normal hydrochloric acid containing 0.015 molar concentration of sodium chloride.
  • the obtained eluate was treated in the same way as in Example 4 to give colorless crystals of disodium salt of guanosine-S-monophosphate.
  • Example 6 A mixture of 97 milligrams of cytidine, 17.6 milligrams of metaboric acid and 8 milliliters of actone was refluxed for 3 hours. The obtained reaction mixture was treated in the same way as in Example 5 and adsorbed on a column of Amberlite CG 400. The column was eluted with 0.002 normal hydrochloric acid. The eluate was treated in the same way as in Example 5 to obtain colorless crystals of disodium salt of cytidine-5'-monophosphate.
  • Example 7 To 300 milliliters of meta-cresol were added 4.75 grams of inosine and 1.12 grams of metaboric acid. The mixture was warmed at 40 C. under stirring for one hour to give a homogeneous solution. After the solution was cooled to 5 C., 40.5 grams of pyrophosphoryl tetrachloride were dropwise added thereto and the mixturewas left for 2 hours. The reaction mixture was poured into ice water and the meta-cresol was extracted with ether. The ether layer was washed with water. The washing and the above obtained water layer were combined, and the combined solution was adjusted to pH 1 with normal sodium hydroxide.
  • Paper electrophoresis borate buifer, pH 9.2) showed that inosine-5-monophosphate was produced in yield of 89%.
  • the solution was diluted with Water and adsorbed on a charcoal column. The column was washed with water and eluted with 0.7% aqueous solution of sodium hydroxide. After the eluate was adjusted to pH 8. 6, it was concentrated and then ethanol added thereto to give crystals of disodium salt of inosine-5'-monophosphate.
  • a method for producing ribonucleoside-5'-phosphate from the corresponding ribonucleoside which comprises reacting the ribonucleoside with metaboric acid, whereby the metaboric acid selectively adds on at the 2'- and 3'-positions on the ribose moiety with formation of borate complex and resultant protection of the hydroxyl group at these positions, and thereupon forthwith subjecting said borate complex to the action of pyrophosphoryl tetrachloride as phosphorylating agent, whereby phosphorylation takes place at the 5'-position, and subsequently bringing the resulting phosphorylated product into contact with water to re-constitute the 2- and 3'-hydroxy groups.
  • the protecting agent is a member selected from the group consisting of metaboric acid and ammonium and alkali metal salts thereof.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)

Description

United States Patent 9 Claims ABSTRACT OF THE DISCLOSURE A method is provided for the production of ribonucleoside-5'-phosphate. In the process, the corresponding ribonucleoside is reacted with metaboric acid and the re sultant product is subsequently reacted with a phosphorylating agent.
This application is a continuation-in-part of application Ser. No. 635,311 filed Apr. 25, 1967, which application is in turn a continuation application of application Ser. No. 435,787, filed Feb. 25, 1965, and both now abandoned.
This invention is concerned with a method for the production of ribonucleoside--phosphate, which comprises reacting the ribonucleoside with metaboric acid and thereupon forthwith reacting the product with phosphorylating agent, and subsequently converting the resulting product into ribonucleoside-5-phosphate by the action of water.
Recently considerable attention has been directed to syntheses of ribonucleoside-5-phosphates, because the compounds have direct bearing on the biologically important ribonucleic acid and nucleotide coenzymes. In addition, disodium salts of nucleoside-5'-phosphates have been used as condiments in the production of various foods, by virtue of their characteristic flavor enhancing or seasoning qualities.
Ribonucleosides have three hydroxyl groups, i.e. one at each of the 2'-, 3'- and 5'-positions on their ribose moiety, and therefore in order to produce ribonucleoside- 5'-phosphate selectively from the corresponding ribonucleoside, it is necessary to protect the hydroxyl groups at the 2- and 3'-positions with suitable substituents prior to the phosphorylation at the 5'-position.
The hitherto known methods for the production of ribonucleoside-5'-phosphates starting with the corresponding ribonucleosides consists of protecting the 2.- and 3- hydroxyl groups on the ribose moiety with acyl groups or isopropylidene groups, followed by phosphorylation of the free 5-hydroxyl group by an appropriate agent and then by removal of the protecting group or groups.
However, the hitherto known methods are bound up with troublesome and disadvantageous steps. That is to say, in addition to a step for the protection of the 2- and 3-hydroxyl groups prior to subsequent phosphorylation at the 5'-position, the methods necessarily include a troublesome step for removing the protecting groups from the phosphorylated product. For example, in case the protecting groups are acyl groups, a treatment with methanolic ammonia must be carried out, and in case the protecting group is an isopropylidene group, the isopropylidene group must be removed by heating the phosphorylated product under acidic conditions in a step subsequent to the phosphorylation reaction, and these manipulations are diificult and disadvantageous from the technical point of view.
Although attempts have been made to overcome the foregoing difiiculties and disadvantages, none, as far as 'we are aware, has been entirely successful when carried into practice commercially on an industrial scale.
The invention in its broader aspects contemplates providing a new selective phosphorylation of the 5'-hydroxyl group on the ribose moiety of ribonucleoside.
It is an object of the present invention to provide a novel method for the production of ribonucleoside-5'- phosphates. Another object of the invention is to make it very simple to remove the protecting groups at the 2'- and 3-positions after the phosphorylation reaction. That is to say, in accordance with the invention, the product resulting from the phosphorylation procedure or the reaction mixture is merely contacted with water to achieve removal of the protecting groups, and therefore the present method for the production of ribonucleoside-5-phos phates is a preferable one from an industrial point of view, as it does not include such troublesome procedures as the deacylation involved in the method heretofore employed in the art, which is far from satisfactory from an industrial point of view. The result, according to the in vention is that ribonucleoside-5'-phosphate can be produced in good yield by simple procedures.
Ribonucleosides in the present specification comprise those containing a purine or pyrimidine base, and include the naturally occurring as Well as the synthetic ribonucleosides.
Briefly stated, the present invention comprises reacting the starting ribonucleoside with metaboric acid and thereupon forthwith reacting the product with phosphorylating agent, and subsequently converting the resulting product into ribonucleoside-5-phosphate by the action of water.
The characteristic feature, in carrying the invention into practice, is that metaboric acid is, first of all, reacted with the starting ribonucleoside to selectively protect the hydroxyl groups at the 2'- and 3'-positions on the ribose moiety of the ribonucleoside.
The rnetaboric acid used in the present invention can either be in free form or in the form of salt such as ammonium salt, sodium salt, etc. The reaction proceeds by heating a mixture of metaboric acid and ribonucleoside in an organic solvent. Any solvent may be used unless the reaction is thereby hindered. Among the solvents which can conveniently be used for the reaction, there are included, for example, alcohols, such as methanol, ethanol and ethylene glycol, ketones such as acetone and methylethyl ketone, ethers such as dioxane and tetrahydrofuran, hydrocarbons such as benzene, toluene and xylene, halogenated hydrocarbons such as carbon tetrachloride, acid amides such as dimethyl amide, esters such as ethyl acetate and butyl acetate, organic bases such as pyridine, phenols such as ortho-, and para-cresol, and mixture thereof. The other conditions, such as reaction temperature and reaction time, are adapted to the particular starting material.
It appears that the compound resulting from the reaction between metaboric acid and ribonucleoside is a borate complex in which metaboric acid forms a complex with the hydroxyl groups at the 2- and 3-positions on the ribose moiety.
The next step in the method of the present invention is phosphorylation of the 5hydroxyl group on the ribose moiety.
In the method of the present invention, the product need not be separated from the reaction mixture, i.e. the latter can be directly phosphorylated, as such.
For the phosphorylation, any of the known methods are applicable. Among the agents which are preferably used for the present phosphorylation, there are included phosphoryl chlorides such as diphenylphosphoryl chloride and dibenzylphosphoryl chloride, phosphoric acid anhy- 3 drides such as O-benzylphosphorus 0,0 diphenylphosphoric acid anhydride and tetra-p-nitrophenyl-pyrophosphoric acid anhydride, pyrophosphoryl mono-, dior tetrachloride, and the mixture of phosphorus oxychloride and water, etc.
The product resulting from the phosphorylation is subsequently brought into contact with water or an organic solvent containing water. In the method of the present invention, the phosphorylated product need not be separated from the reaction mixture, but the latter can directly be brought into contact with water, or an organic solvent containing water. In this case, it is generally preferable to employ cold water or aqueous alkaline solution. By this procedure, i.e. by the action of the water, the protecting group is removed, that is to say, the metaboric acid is removed from the borate complex, with the result that the protected hydroxyl groups at the 2- and 3'- position on the ribose moiety are changed back into free hydroxyl groups.
The present method is extremely advantageous from the industrial point of view. In contrast with the hitherto known methods, the present method is characterized by extreme simplicity of procedure for removal of any protecting groups.
The resulting final product, i.e. ribonucleoside-'-phosphate can be isolated from the reaction mixture by methods per se well known in the art, for example using ion-exchange resins or active carbon, or by crystallizing in a form of salt such as sodium salt, barium salt, potassium salt, amino acid salt, etc.
As detailed above, by the present invention, ribonucleoside5-phosphate can be obtained in very simple procedure and under very moderate conditions as compared with those of known methods, and yet the reaction is completed in a short period of time. Moreover, the 5'-phosphate is obtained in high purity and good yield.
For the purpose of giving those skilled in the art a better understanding of the invention, the following illustrative examples of presently preferred embodiments are given. In these examples, percentages are by weight unless otherwise specified.
Example 1 To 300 milliliters of meta-cresol were added 5 grams of adenosine, 1.12 grams of metaboric acid and 72 milliliters of acetone. The mixture was warmed at 40 C. under stirring for one hour to give a solution. After the solution was cooled to 5 C., 40.5 grams of pyrophosphoryl tetrachloride were dropwise added thereto and the mixture was left for 3 hours. The reaction mixture was poured ether. The ether layer was washed with water. The washing and the above-obtained ice water layer were combined, and the combined solution was adjusted to pH 1 with normal solution of sodium hydroxide. Paper electrophoresis showed that adenosine-S-monophosphate was produced in yield of 92%.
Example 2 To a suspension of 133 milligrams of well dried adenosine in milliliters of acetone, were added 22 milligrams of metaboric acid. The mixture was heated at 70 C. for 3 hours and the solvent evaporated under reduced pressure. One milliliter of pyrophosphoryl tetrachloride was added to the residue under ice cooling and the mixture was left standing at 10 C. for 3 hours to give a homogeneous solution, which was poured into ice water. The mixture was adjusted to pH 1 with normal solution of sodium hydroxide and then adsorbed on a charcoal column. The column was washed with water and eluted with 50% aqueous ethanol containing 0.5% by volume of ammonium hydroxide. The eluate was concentrated and examined by paper electrophoresis (0.05 mol borate, pH 9.2). This showed that adenosine-5-monophosphate was produced in yield of 70%. The concentrate was poured onto a column of Amberlite C6400 (C1 form), which was into ice Water, and meta-cresol was extracted with eluted with 0.003 normal hydrochloric acid. After the obtained eluate was adsorbed on a charcoal column, the column was washed with water and eluted with aforesaid ethanol solution. The eluate was concentrated after the addition of sodium hydroxide and then ethanol was added thereto to give colorless crystals of disodium salt of adenosine-5'-monophosphate.
Example 3 To a solution of 107 milligrams of inosine in 8 milliliters of dimethylformamide, were added 17.6 milligrams of metaboric acid. The mixture was heated at 70 C. for 3 hours and the solvent evaporated under reduced pressure. 0.8 milliliter of pyrophosphoryl tetrachloride was added to the residue under ice cooling and the mixture was left standing at 10 C. for 3 hours to give a homogeneous solution. The solution was treated in the same way as in Example 2. Paper electrophoresis showed that inosine-5'-monophosphate was produced in yield of The solution was applied on top of a column of Amberlite C6400 (C1 form), which was eluted with 0.003 normal hydrochloric acid containing 0.02 molar concentration of sodium chloride. The obtained eluate was treated in the same way as in Example 2 to give colorless crystals of disodium salt of inosine-5-monophosphate.
Example 4 To 107 milligrams of inosine dissolved in 16 milliliters of acetone, were added 17.6 milligrams of metaboric acid. After the mixture was refiuxed for 30 minutes, it was subsequently treated in the same way as in Example 3 to give disodium salt of inosine-5'-monophosphate.
Example 5 A mixture of 113 milligrams of guanosine, l8 milligrams of metaboric acid and 8 milliliters of actone was refluxed for 3 hours and the acetone evaporated under reduced pressure. 08 milliliter of pyrophosphoryl tetrachloride -was added to the residue under ice cooling and the mixture was left standing at 10 C. for 3 hours to give a homogeneous solution. The solution was poured into 20 milliliters of normal sodium hydroxide solution to adjust to pH 2, and was adsorbed on a charcoal column. The column was washed with water and eluted. The eluate was applied on top of a column of Amberlite CG 400 (C1 form), which was eluted with 0.003 normal hydrochloric acid containing 0.015 molar concentration of sodium chloride. The obtained eluate was treated in the same way as in Example 4 to give colorless crystals of disodium salt of guanosine-S-monophosphate.
Example 6 A mixture of 97 milligrams of cytidine, 17.6 milligrams of metaboric acid and 8 milliliters of actone was refluxed for 3 hours. The obtained reaction mixture was treated in the same way as in Example 5 and adsorbed on a column of Amberlite CG 400. The column was eluted with 0.002 normal hydrochloric acid. The eluate was treated in the same way as in Example 5 to obtain colorless crystals of disodium salt of cytidine-5'-monophosphate.
Example 7 To 300 milliliters of meta-cresol were added 4.75 grams of inosine and 1.12 grams of metaboric acid. The mixture was warmed at 40 C. under stirring for one hour to give a homogeneous solution. After the solution was cooled to 5 C., 40.5 grams of pyrophosphoryl tetrachloride were dropwise added thereto and the mixturewas left for 2 hours. The reaction mixture was poured into ice water and the meta-cresol was extracted with ether. The ether layer was washed with water. The washing and the above obtained water layer were combined, and the combined solution was adjusted to pH 1 with normal sodium hydroxide. Paper electrophoresis borate buifer, pH 9.2) showed that inosine-5-monophosphate was produced in yield of 89%. The solution was diluted with Water and adsorbed on a charcoal column. The column was washed with water and eluted with 0.7% aqueous solution of sodium hydroxide. After the eluate was adjusted to pH 8. 6, it was concentrated and then ethanol added thereto to give crystals of disodium salt of inosine-5'-monophosphate.
Having thus disclosed the invention, what is claimed 1s:
1. A method for producing ribonucleoside-5'-phosphate from the corresponding ribonucleoside, which comprises reacting the ribonucleoside with metaboric acid, whereby the metaboric acid selectively adds on at the 2'- and 3'-positions on the ribose moiety with formation of borate complex and resultant protection of the hydroxyl group at these positions, and thereupon forthwith subjecting said borate complex to the action of pyrophosphoryl tetrachloride as phosphorylating agent, whereby phosphorylation takes place at the 5'-position, and subsequently bringing the resulting phosphorylated product into contact with water to re-constitute the 2- and 3'-hydroxy groups.
2. The method as claimed in claim 1, wherein the ribonucleoside is inosine.
3. The method as claimed in claim 1, wherein the ribonucleoside is quanosine.
4. The method as claimed in claim 1, wherein the ribonucleoside is adenosine.
5. The method as claimed in claim 1, wherein the ribonucleoside is cytidine.
6. The method as claimed in ribonucleoside is uridine.
7. The method as claimed in claim 1, wherein the metaboric acid is in the form of ammonium salt thereof.
8. The method as claimed in claim 1, wherein the metaboric acid is in the form of alkali metal salt thereof.
9. In a method for producing ribonucleoside-5-phosphate from the corresponding ribonucleoside by phosphorylation preceded by protection of the 2'- and 3-OH groups of the ribonucleoside, the improvement according to which the protecting agent is a member selected from the group consisting of metaboric acid and ammonium and alkali metal salts thereof.
claim 1, wherein the References Cited UNITED STATES PATENTS 3,067,192 12/ 1-962 Emrick 260-234 3,201,389 8/1965 Fujimoto et al. 260-2115 3,231,561 1/ 1966 Brunelle et a1 2'60234 LEWIS GOTTS, Primary Examiner. J. R. BROWN, Assistant Examiner.
US650661A 1967-07-03 1967-07-03 Method for the production of ribonucleoside-5'-phosphate Expired - Lifetime US3433783A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65066167A 1967-07-03 1967-07-03

Publications (1)

Publication Number Publication Date
US3433783A true US3433783A (en) 1969-03-18

Family

ID=24609778

Family Applications (1)

Application Number Title Priority Date Filing Date
US650661A Expired - Lifetime US3433783A (en) 1967-07-03 1967-07-03 Method for the production of ribonucleoside-5'-phosphate

Country Status (1)

Country Link
US (1) US3433783A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056673A (en) * 1976-07-16 1977-11-01 Hoffmann-La Roche Inc. Phosphonoacetic acid derivatives of nucleosides
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
US5623069A (en) * 1992-07-08 1997-04-22 Takeda Chemical Industries, Ltd. Method for producing 5'-nucleotide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067192A (en) * 1958-06-11 1962-12-04 Standard Oil Co Process for preparing acyl polysac-charide borates
US3201389A (en) * 1962-09-24 1965-08-17 Kyowa Hakko Kogyo Kk Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides
US3231561A (en) * 1962-01-03 1966-01-25 Economics Lab Fatty acid sugar esters and fatty acid sugar-boron esters

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067192A (en) * 1958-06-11 1962-12-04 Standard Oil Co Process for preparing acyl polysac-charide borates
US3231561A (en) * 1962-01-03 1966-01-25 Economics Lab Fatty acid sugar esters and fatty acid sugar-boron esters
US3201389A (en) * 1962-09-24 1965-08-17 Kyowa Hakko Kogyo Kk Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056673A (en) * 1976-07-16 1977-11-01 Hoffmann-La Roche Inc. Phosphonoacetic acid derivatives of nucleosides
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
US5623069A (en) * 1992-07-08 1997-04-22 Takeda Chemical Industries, Ltd. Method for producing 5'-nucleotide

Similar Documents

Publication Publication Date Title
US3201389A (en) Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides
Marumoto et al. Synthesis and coronary vasodilating activity of 2-substituted adenosines
US4760137A (en) Method for the production of 2'-deoxyadenosine compounds
Ralph et al. Studies on Polynucleotides. XVIII. 1 Experiments on the Polymerization of Mononucleotides. The Synthesis and Characterization of Deoxyguanosine Oligonucleotides 2
Saffhill Selective phosphorylation of the cis-2', 3'-diol of unprotected ribonucleosides with trimetaphosphate in aqueous solution
US2719843A (en) Method of synthesizing nucleosides and analogous compounds and compounds prepared thereby
EP0173059A2 (en) Method for the production of 2'-deoxyadenosine compounds
Wechter Nucleic acids. I. The synthesis of nucleotides and dinucleoside phosphates containing ara-cytidine
US2844514A (en) Process for the production of nucleotides
US3337530A (en) Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety
US3433783A (en) Method for the production of ribonucleoside-5'-phosphate
US3300478A (en) Arabinofuranosyl 2', 5'-and 3'-5'-dinucleoside phosphates and process therefor
Baron et al. Nucleotides. Part XXXIII. The structure of cytidylic acids a and b
US3709873A (en) Process for synthesizing the di-esters of condensed phosphoric acid
US3201388A (en) Method of preparing 5'-ribonucleotides
US3787392A (en) Process for the preparation of nucleoside diphosphate esters
US3221010A (en) 5,6-substituted dihydro-5-fluoropyrimidine nucleosides
US3407190A (en) Method for the production of 5'-ribonucleotide
Nishino et al. Partial protection of carbohydrate derivatives. part 18. simple, preparative procedure for 5'-o-acylribonucleosides; highly regioselective o-deacylation at 2'and 3'positions of fully acylated purine and pyrimidine ribonucleoside through sodium methoxide-thf system
US3382232A (en) Method for the production of 5'-ribonucleotide
US3288780A (en) Process for preparing 5'-ribonucleotides
US3346562A (en) Method for the production of ribonucleoside-5'-phosphate
US3347846A (en) Method of preparing 5'-ribonucleotide
US3318866A (en) Process for making partial o-acylates of lincomycin
US3406166A (en) Method for producing ribonucleoside-5'-phosphate